| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023415348 |
| P356 | DOI | 10.1186/BCR3337 |
| P932 | PMC publication ID | 4053113 |
| P698 | PubMed publication ID | 23095343 |
| P5875 | ResearchGate publication ID | 232698776 |
| P50 | author | Lars A. Akslen | Q11983239 |
| Solveig Hofvind | Q87787736 | ||
| Tom Grotmol | Q114094497 | ||
| Ali Ozhand | Q125332114 | ||
| Giske Ursin | Q46387795 | ||
| P2093 | author name string | Eunjung Lee | |
| David J Van Den Berg | |||
| Elisabeth Couto | |||
| Merete Ellingjord-Dale | |||
| Samera Qureshi | |||
| P2860 | cites work | Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression | Q24626916 |
| Genetic determinants of mammographic density | Q24807377 | ||
| Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study | Q24810286 | ||
| A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF | Q28296638 | ||
| Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study | Q28365602 | ||
| Breast tissue composition and susceptibility to breast cancer | Q30474496 | ||
| Snagger: a user-friendly program for incorporating additional information for tagSNP selection | Q33326038 | ||
| Can genes for mammographic density inform cancer aetiology? | Q33635885 | ||
| Heritability of mammographic density, a risk factor for breast cancer | Q48611340 | ||
| Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. | Q51739138 | ||
| Polymorphisms in the estrogen receptor alpha gene and mammographic density. | Q54631662 | ||
| Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women | Q56882445 | ||
| Associations among Mammographic Density, Circulating Sex Hormones, and Polymorphisms in Sex Hormone Metabolism Genes in Postmenopausal Women | Q57202712 | ||
| Mapping of Two Phenol Sulfotransferase Genes, STP and STM, to 16p: Candidate Genes for Batten Disease | Q57252326 | ||
| Prolactin synthesis and secretion by human breast cancer cells | Q72312399 | ||
| Growth factors and stromal matrix proteins associated with mammographic densities | Q73754400 | ||
| Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues | Q74189226 | ||
| An investigation of mammographic density and gene variants in healthy women | Q80594395 | ||
| Hormone therapy use and mammographic density in postmenopausal Norwegian women | Q82337997 | ||
| Relative imbalances in the expression of catechol-O-methyltransferase and cytochrome P450 in breast cancer tissue and their association with breast carcinoma | Q83781667 | ||
| Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort | Q34048111 | ||
| Mapping of prolactin and tumor necrosis factor-beta genes on human chromosome 6p using lymphoblastoid cell deletion mutants | Q34462166 | ||
| Using mammographic density to predict breast cancer risk: dense area or percentage dense area | Q34613556 | ||
| Associations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentrations in premenopausal women in the United States | Q34730731 | ||
| Common variants in ZNF365 are associated with both mammographic density and breast cancer risk | Q34792833 | ||
| Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity | Q35012719 | ||
| The role of prolactin in mammary carcinoma | Q35067253 | ||
| Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism | Q35187748 | ||
| Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland | Q35559023 | ||
| Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study | Q35836312 | ||
| Circulating levels of inflammatory markers and mammographic density among postmenopausal women | Q36201439 | ||
| Mammographic density, breast cancer risk and risk prediction | Q36465317 | ||
| Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
| Prolactin acts as a potent survival factor for human breast cancer cell lines. | Q36695290 | ||
| Reproductive role of prolactin | Q36739098 | ||
| Breast cancer susceptibility loci and mammographic density | Q36955118 | ||
| Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). | Q37147580 | ||
| Predictors of mammographic density: insights gained from a novel regression analysis of a twin study | Q37179473 | ||
| Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women | Q37360198 | ||
| Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk | Q37393210 | ||
| TNF-alpha polymorphisms and breast cancer | Q37863045 | ||
| Estrogen pathway polymorphisms and mammographic density | Q37971376 | ||
| Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program | Q40200396 | ||
| Genetic analysis of mammographic breast density in adult women: evidence of a gene effect | Q43940206 | ||
| Mammographic density and intake of selected nutrients and vitamins in Norwegian women | Q44164977 | ||
| Postmenopausal hormone therapy and change in mammographic density | Q44267695 | ||
| Polymorphisms in steroid hormone pathway genes and mammographic density | Q44325849 | ||
| Polymorphism in CYP17, GSTM1 and the progesterone receptor genes and its relationship with mammographic density. | Q46070033 | ||
| Polymorphism in the androgen receptor and mammographic density in women taking and not taking estrogen and progestin therapy | Q46111312 | ||
| Mammographic density and breast cancer in three ethnic groups | Q46311063 | ||
| The relative importance of genetics and environment on mammographic density | Q46442559 | ||
| The role of established breast cancer susceptibility loci in mammographic density in young women | Q46477592 | ||
| Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial | Q46713495 | ||
| 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment | Q46719152 | ||
| Analysis of mammographic density and breast cancer risk from digitized mammograms | Q48589359 | ||
| Alcohol intake and mammographic density in postmenopausal Norwegian women | Q48602320 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | R135 | |
| P577 | publication date | 2012-10-27 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users | |
| P478 | volume | 14 |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q37279259 | Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects |
| Q92307692 | Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes |
| Q37087852 | Genetic variation in transforming growth factor beta 1 and mammographic density in Singapore Chinese women |
| Q45024538 | Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21. |
| Q58605247 | Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study |
| Q34338914 | Hormone metabolism genes and mammographic density in Singapore Chinese women |
| Q59799817 | Mammographic density and breast tissue expression of inflammatory markers, growth factors, and vimentin |
| Q34769802 | Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. |
| Q35566838 | Vitamin D intake, month the mammogram was taken and mammographic density in Norwegian women aged 50-69 |
Search more.